E-LIB Suche - Ergebnisse für: Wege, H.

1

Characteristics and outcomes of immunotherapy-related liver..:

Celsa, C. ; Cabibbo, G. ; Fulgenzi, C. AM...
Digestive and Liver Disease. 56 (2024) - p. S76-S78 , 2024

Link: https://doi.org/10.1016/..

2

Identification of factors associated with primary refractor..:

Manfredi, G.F. ; Fulgenzi, C.A.M. ; D'Alessio, A....
Digestive and Liver Disease. 56 (2024) - p. S8-S9 , 2024

Link: https://doi.org/10.1016/..

3

Standards und Entwicklungen in der Behandlung von Cholangio..:

Wege, H. ; Denecke, T. ; Petersen, C...
best practice onkologie. 15 (2020) 4 - p. 134-140 , 2020

Link: https://doi.org/10.1007/..

4

Vaccinia-based oncolytic immunotherapy Pexastimogene Devaci..:

Moehler, M. ; Heo, J. ; Lee, H.C....
OncoImmunology. 8 (2019) 8 - p. , 2019

Link: https://doi.org/10.1080/..

5

Serological diagnosis of early HCC in NASH: A German multic..:

Best, J. ; Bechmann, L. ; Dechêne, A....
Journal of Hepatology. 68 (2018) - p. S421-S422 , 2018

Link: https://doi.org/10.1016/..

6

EpCAM-positive circulating tumor cells as liquid biomarker ..:

Schulze, K. ; von Felden, J. ; Krech, T....
Journal of Hepatology. 66 (2017) 1 - p. S457 , 2017

Link: https://doi.org/10.1016/..

7

Aktuelle Therapiekonzepte für lokale Cholangiokarzinome:

Seehofer, D. ; Brunner, T.B. ; Wege, H.
Der Onkologe. 21 (2015) 11 - p. 1054-1063 , 2015

Link: https://doi.org/10.1007/..

8

P1310 : Adjuvant chemotherapy with gemcitabine and cisplati..:

Wege, H. ; Arnold, D. ; Bechstein, W.O....
Journal of Hepatology. 62 (2015) - p. S845 , 2015

Link: https://doi.org/10.1016/..

9

P0302 : Constitutive gp130 activation accelerates transform..:

Gil-Ibanez, I. ; Heim, D. ; Herden, J....
Journal of Hepatology. 62 (2015) - p. S421-S422 , 2015

Link: https://doi.org/10.1016/..

10

P1334 : A multicentre, randomised, open-label study compari..:

Merle, P. ; Pelletier, G. ; Habersetzer, F....
Journal of Hepatology. 62 (2015) - p. S856-S857 , 2015

Link: https://doi.org/10.1016/..

11

1091 MULTI-COLOUR RGB MARKING TO ASSESS THE CLONALITY OF LI..:

Thomaschewski, M. ; Weber, K. ; Cornils, K....
Journal of Hepatology. 58 (2013) - p. S446 , 2013

Link: https://doi.org/10.1016/..

12

92 FORCED IL-6 SIGNALING IS SUFFICIENT TO PROMOTE MALIGNANT..:

Heim, D. ; Parplys, A.C. ; Rose-John, S....
Journal of Hepatology. 58 (2013) - p. S40-S41 , 2013

Link: https://doi.org/10.1016/..

13

Systemtherapie des Leberzellkarzinoms:

Wege, H. ; Arnold, D.
Der Onkologe. 18 (2012) 7 - p. 602-610 , 2012

Link: https://doi.org/10.1007/..

14

291 DIFFERENTIAL EVALUATION OF DIRECT ONCOGENIC EFFECTS OF ..:

Meiners, J. ; Heim, D. ; Lohse, A.W..
Journal of Hepatology. 56 (2012) - p. S120 , 2012

Link: https://doi.org/10.1016/..

15

79 SORAFENIB PLUS TACE FOR THE TREATMENT OF ADVANCED HEPATO..:

Erhardt, A. ; Kolligs, F.T. ; Dollinger, M....
Journal of Hepatology. 54 (2011) - p. S35 , 2011

Link: https://doi.org/10.1016/..